Triplet pregnancy after ovulation induction with an aromatase inhibitor.
OBJECTIVE
To describe the first reported case of a triplet pregnancy subsequent to the use of an aromatase inhibitor for ovulation induction.


METHODS
Case report.


METHODS
Academic medical center.


METHODS
A 32-year-old female with polycystic ovary syndrome and primary infertility.


METHODS
Letrozole, 5 mg/day, on cycle days 2 to 6 for ovulation induction.


METHODS
Clinical pregnancy.


RESULTS
Viable triplet gestation.


CONCLUSIONS
Use of an aromatase inhibitor for ovulation induction does not eliminate the risk for higher order multiple pregnancy.
Dicken
Cary L
CL
Department of Obstetrics and Gynecology, Center for Women's Reproductive Care, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
Nakhuda
Gary S
GS
Guarnaccia
Michael M
MM
Sauer
Mark V
MV
Lobo
Rogerio A
RA
D000328:Adult; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D016896:Treatment Outcome; D014310:Triplets
D047072:Aromatase Inhibitors; D005300:Fertility Agents, Female